Cellnovo Stock

Stocks

CLNV

FR0012633360

Software

Real-time Euronext Paris 5-day change 1st Jan Change
- EUR -.--% Intraday chart for Cellnovo -.--% -

Valuation: Cellnovo

Market Cap 2.44M 2.14M 1.99M 1.83M 3.43M 233M 3.49M 23.61M 9.24M 115M 9.14M 8.95M 399M P/E 2018 *
-0.15x
P/E 2019 * -
Enterprise Value 12.46M 10.93M 10.18M 9.36M 17.55M 1.19B 17.85M 121M 47.28M 590M 46.77M 45.76M 2.04B EV / Sales 2018
8.63x
EV / Sales 2019 * -
Free-Float
99.67%
Yield 2018 *
-
Yield 2019 * -
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 2.68M
-1.71%-3.51% - - 20.77B
+0.29%-2.55%-37.68%-10.88% 15.51B
+5.53%+4.61%-50.77%-55.34% 8.02B
-0.77%-17.88%+2.42%+75.97% 6.86B
+3.66%+2.20%-33.12%+237.26% 4.27B
+1.55%-6.09%-35.65%-21.22% 2.29B
+2.82%+3.41%-34.77%-37.99% 1.89B
+2.09%+3.11%+26.00%+88.91% 1.56B
+3.06%+4.73%+6.11%+46.07% 1.39B
Average +1.00%-1.27%-19.68%+40.35% 6.26B
Weighted average by Cap. -0.18%-2.69%-29.07%+24.01%

Financials

2018 2019 *
Net sales 3.32M 2.92M 2.71M 2.5M 4.68M 317M 4.76M 32.21M 12.61M 157M 12.47M 12.2M 544M -
Net income -15.94M -13.99M -13.03M -11.98M -22.46M -1.52B -22.84M -155M -60.49M -755M -59.84M -58.55M -2.61B -
Net Debt 10.02M 8.8M 8.19M 7.53M 14.12M 957M 14.36M 97.17M 38.03M 475M 37.63M 36.81M 1.64B -
Logo Cellnovo
Cellnovo Group SA is a France-based company principally engaged in medical instrument manufacturing . The Company specialized in the development of a mobile system for managing type 1 diabetes. Its apparatus includes a cordless micro-pump (a patch pump), an integrated monitoring device and a cellular handset with touch screen with an embedded blood glucose meter. The Company system enables diabetics to live a normal life whilst closely monitoring their glycaemia, their use of insulin, their activity and their food intake.
Employees
-
  1. Stock Market
  2. Stocks
  3. CLNV Stock